Craig W. Philips - Net Worth and Insider Trading
Craig W. Philips Net Worth
The estimated net worth of Craig W. Philips is at least $749,619 dollars as of 2024-12-01. Craig W. Philips is the President of CTI BioPharma Corp and owns about 78,633 shares of CTI BioPharma Corp (CTIC) stock worth over $714,774. Craig W. Philips is also the President of Kineta Inc and owns about 95,465 shares of Kineta Inc (KANT) stock worth over $34,845. Details can be seen in Craig W. Philips's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Craig W. Philips has not made any transactions after 2023-11-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Craig W. Philips
Craig W. Philips Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Craig W. Philips owns 3 companies in total, including CTI BioPharma Corp (CTIC) , Yumanity Therapeutics Inc (YMTX) , and Kineta Inc (KANT) .
Click here to see the complete history of Craig W. Philips’s form 4 insider trades.
Insider Ownership Summary of Craig W. Philips
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2012-06-29 | President |
| YMTX | Yumanity Therapeutics Inc | 2022-12-16 | President |
| KANT | Kineta Inc | 2023-11-28 | President |
Craig W. Philips Latest Holdings Summary
Craig W. Philips currently owns a total of 2 stocks. Among these stocks, Craig W. Philips owns 78,633 shares of CTI BioPharma Corp (CTIC) as of June 29, 2012, with a value of $714,774 and a weighting of 95.35%. Craig W. Philips also owns 95,465 shares of Kineta Inc (KANT) as of November 28, 2023, with a value of $34,845 and a weighting of 4.65%.
Latest Holdings of Craig W. Philips
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTIC | CTI BioPharma Corp | 2012-06-29 | 78,633 | 9.09 | 714,774 |
| KANT | Kineta Inc | 2023-11-28 | 95,465 | 0.37 | 34,845 |
Holding Weightings of Craig W. Philips
Craig W. Philips Form 4 Trading Tracker
According to the SEC Form 4 filings, Craig W. Philips has made a total of 0 transactions in CTI BioPharma Corp (CTIC) over the past 5 years. The most-recent trade in CTI BioPharma Corp is the sale of 1,840 shares on June 29, 2012, which brought Craig W. Philips around $52,440.
According to the SEC Form 4 filings, Craig W. Philips has made a total of 3 transactions in Kineta Inc (KANT) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Kineta Inc is the acquisition of 3,000 shares on November 28, 2023, which cost Craig W. Philips around $9,810.
Insider Trading History of Craig W. Philips
- 1
Craig W. Philips Trading Performance
GuruFocus tracks the stock performance after each of Craig W. Philips's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Craig W. Philips is 14.16%. GuruFocus also compares Craig W. Philips's trading performance to market benchmark return within the same time period. The performance of stocks bought by Craig W. Philips within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Craig W. Philips's insider trading performs compared to the benchmark.
Performance of Craig W. Philips
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.16 | | | | | |
| Relative Return to S&P 500(%) | 32.87 | | | | | |
Craig W. Philips Ownership Network
Craig W. Philips Owned Company Details
What does CTI BioPharma Corp do?
Who are the key executives at CTI BioPharma Corp?
Craig W. Philips is the President of CTI BioPharma Corp. Other key executives at CTI BioPharma Corp include EVP & Chief Commercial Officer James K Fong , director & President and CEO Adam R Craig , and EVP & Chief Financial Officer David Kirske .
CTI BioPharma Corp (CTIC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp (CTIC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CTI BioPharma Corp (CTIC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CTI BioPharma Corp (CTIC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CTI BioPharma Corp Insider Transactions
Craig W. Philips Mailing Address
Above is the net worth, insider trading, and ownership report for Craig W. Philips. You might contact Craig W. Philips via mailing address: C/o Kineta, Inc., 219 Terry Ave. N., Suite 300, Seattle Wa 98109.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
